Evidence map›Paper›PMID 21916808›Full record

ReviewAIDS research and human retroviruses2012

cAMP during HIV infection: friend or foe?

Maria E Moreno-Fernandez, Cesar Mauricio Rueda, Paula A Velilla, Maria Teresa Rugeles, Claire A Chougnet

Open access · greenAbstract readReview
In one paragraph

Review in AIDS research and human retroviruses, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Prostaglandin EInfection and immunity · 2022
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Regulatory T cells: the ultimate HIV reservoir?Journal of virus eradication · 2018
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Regulatory T cells and the risk of CMV end-organ disease in patients with AIDS.Journal of acquired immune deficiency syndromes (1999) · 2014
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Maria E Moreno-FernandezDivision of Molecular Immunology, Cincinnati Children's Hospital Research Foundation, Department of Pediatrics, Immunobiology Graduate Program University of Cincinnati, College of Medicine, Ohio 45229, USA.
Cesar Mauricio Rueda
Paula A Velilla
Maria Teresa Rugeles
Claire A Chougnet
Universidad de Antioquia · CO

Funding

Role of Regulatory T Cells in HIV InfectionR01AI068524 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI CHOUGNET, CLAIRE A. · 2006 to 2010
$1.8M
NIAID NIH HHS AI068524
6 · The paper itself

Abstract

Intracellular levels of cyclic adenosine 3',5'-monophosphate (cAMP) are important regulators of immune cells, partially determining the balance between activation and suppression. In this review, we discuss the mechanisms by which HIV infection increases cAMP levels in T cells, as well as the effect of cAMP on HIV-specific responses and its effect on HIV replication and infection. Results suggest that increased cAMP levels during HIV infection may have a dual and opposite roles. On the one hand, they could have a protective effect by limiting viral replication in infected cells and decreasing viral entry. On the other hand, they could have a detrimental role by reducing HIV-specific antiviral immune responses, thus reducing the clearance of the virus and contributing to T cell dysfunction. Future studies are thus needed to further define the beneficial versus detrimental roles of cAMP, as they could help establish new therapeutic targets to combat HIV replication and/or identify novel ways to boost antiviral immune responses.

Indexed as

Cyclic AMPHIV-1HIV InfectionsHumansLymphocyte ActivationT-LymphocytesT-Lymphocytes, RegulatoryVirus ReplicationCyclic AMP

Identifiers

PMID21916808
PMCPMC3251837
OpenAlexW1969569273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.